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Introduction: The coronavirus disease‐2019 (COVID‐19) era is a challenging time
for respiratory teams to protect their patients and staff. COVID‐19 is predominantly
transmitted by respiratory droplets; in the clinical setting, aerosol generating pro-
cedures pose the greatest risk for COVID‐19 transmission. Bronchoscopy is asso-
ciated with increased risk of patient‐to‐health care worker transmission, owing to
aerosolized viral particles which may be inhaled and also result in environmental
contamination of surfaces.
Methods: We describe our experience with the use of modified full‐face snorkeling
masks for pediatric bronchoscopy procedures in four COVID‐19 infected children
when filtering facepieces/respirators were in limited supply.
Results: Bronchoscopy was urgently required in four children, and could not be
delayed until COVID‐19 test results were available. During the pandemic peak,
when respirators were in short supply, modified full‐face snorkel masks (SEAC
Libera, SEAC, Italy) were worn by the bronchoscopy team. Each mask was fitted with
an O‐ring, adapter, and heat and moisture exchanger filter. To date, there have been
no COVID‐19 infections among the bronchoscopy team staff, whereas the overall
Hospital staff COVID‐19 prevalence rate has exceeded 13.5% (667/4949).
Conclusion: Emergency bronchoscopy procedures on COVID‐19 infected patients or
patients with unknown infection status can be safely performed using modified full‐
face snorkel masks.
K E YWORD S
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1 | INTRODUCTION
The emergence and rapid global spread of severe acute
respiratory syndrome coronavirus‐2 (SARS‐COV‐2) resulting
in coronavirus disease 2019 (COVID‐19) initially reported in
Wuhan, China has been well documented. The first case in South
Africa was diagnosed on 5 March 2020,1 but initial transmission
rates were low, following enactment of a national lockdown on 27
March 2020. Since the relaxation of lockdown restrictions, the
country has experienced exponential increase in COVID‐19
infections, with 196 750 confirmed cases in South Africa, and
the Western Cape having the highest burden of cases with a total
of 69 531 cases (35.3%) on the 5th of July. Tygerberg Hospital, an
academic, public hospital in Cape Town, is one of two major
referral hospitals for COVID‐19 infected patients in the Western
Cape Province. Owing to the limited local and national laboratory
capacity for SARS‐CoV‐2 testing and the huge public demand for
testing at the peak of the pandemic in Cape Town, our hospital
limited testing of hospitalized children to those presenting with
symptoms and signs meeting the national criteria2 for COVID‐19
investigation. The turnaround time for SARS‐CoV‐2 reverse
transcription‐polymerase chain reaction (RT‐PCR) results at our
hospital has varied from 24 to 72 hours for hospitalized patients,
and rapid testing before emergency surgery and procedures was
not readily available in the first months of the pandemic. Since
March 2020, the hospital's pediatric service has screened 768
children for COVID‐19, of whom 128 were COVID ‐19 positive
(16.7% test positivity rate); 37/128 (28.9%) required hospital
admission.
In community settings, COVID‐19 is predominantly transmitted
through respiratory droplets, although recent studies suggest that
aerosol transmission may also occur.3‐6 In the clinical setting, aerosol
generating procedures (AGP) pose the greatest risk for COVID‐19
transmission.7 These procedures include high‐flow oxygen delivery
(HFO), continuous positive airway pressure delivery (CPAP), in-
tubation, suctioning, and bronchoscopy. The use of these modalities
and procedures is associated with increased risk of patient‐to‐health
care worker transmission, owing to aerosolized viral particles which
may be inhaled and also result in environmental contamination of
surfaces.8‐10
Although the role of children in the transmission of SARS‐CoV‐2
in the community is thought to be limited,11 the risk of transmission
to health care workers (HCWs) performing AGPs on COVID‐19 in-
fected children is likely to be significant, although,12 further research
is needed. For this reason, children undergoing AGP's should undergo
SARS‐COV‐2 testing preprocedure. In the case of emergency pro-
cedures (as described in this case series), and/or where rapid
SARS‐COV‐2 testing is not possible, all HCWs in the procedure room
should apply airborne precautions and additional administrative
measures, environmental controls, and different personal protective
equipment requirements to reduce COVID‐19 transmission risk.13,14
In addition, the phenomenon of asymptomatic COVID‐19 infection,
particularly in children, poses an additional risk to staff undertaking
AGP's, with potential for unexpected transmission of COVID‐19
to HCWs.
The COVID‐19 era is a challenging time for respiratory teams to
protect their patients and staff. For COVID‐19 infected or suspected
patients undergoing AGPs (eg, cardiopulmonary resuscitation), the
European Resuscitation Council guidelines advocate for the use of: a
long‐sleeved gown, a filtering facepiece (FFP3 or N99 respirator;
FFP2 or N95 if FFP3 not available); and eye and face protection (full‐
face shield/visor or polycarbonate safety glasses). Where filtering
facepieces are not available, the resuscitation council guidelines re-
commend use of powered air purifying respirators (PAPR) with
hoods.15 However, owing to global personal protective equipment
(PPE) shortages and supply chain challenges, many hospitals have
had to procure alternatives to traditional PPE.
2 | METHODS
We describe our experience with pediatric bronchoscopy in four
COVID‐19 infected children, whose COVID‐19 PCR results were not
available preprocedure and share our experience of adapting full‐face
snorkeling masks for use in AGPs when filtering facepieces/re-
spirators were in limited supply.
Permission to report this case series was granted by the In-
stitutional Review Board of the Health Science Faculty of Stellen-
bosch University (HREC N20/04/013).
2.1 | Case series
2.1.1 | Case 1
A 1 year and 8‐month‐old male presented with an acute history of
difficulty breathing for 1 day. No fever, cough, or choking episode
was reported. He was not known to be in contact with persons with
COVID‐19 or tuberculosis (TB). Upon arrival to casualty he was no-
ted to have severe respiratory distress and was wheezing. Emergency
care included metered dose inhaled salbutamol with a spacer and
face mask, magnesium sulfate infusion, intravenous dexamethasone,
and an intravenous salbutamol loading dose. Nasal‐CPAP was started
in the emergency room. After an initial brief improvement he wor-
sened and had an asystolic arrest. He was resuscitated and intubated,
with re‐establishment of circulation after 20minutes; he was sub-
sequently transferred to the pediatric intensive care unit. His initial
chest radiograph showed hyperinflation and no significant par-
enchymal air‐space disease (Figure 1). The sudden onset of symptoms
and the initial presentation had raised concerns of foreign body as-
piration. Bronchoscopy was performed with a 3.0 mm videoscope via
a 4.0mm endotracheal tube to assess the airway. Bronchoscopy
confirmed thick pus in the left and right sided airways but a foreign
body was excluded. The child improved rapidly and was extubated to
HFO; his SARS‐CoV‐2 RT‐PCR result that had been sent on pre-
sentation was confirmed as positive on day 2 of hospitalization. A
nasopharyngeal aspirate also collected on admission was positive for
rhinovirus and cytomegalovirus (CMV), but a plasma CMV‐viral load
was undetectable. Bacterial cultures on a tracheal aspirate and Xpert
MTB/RIF were negative. The child had no known COVID‐19 ex-
posures and his mother's COVID‐19 RT‐PCR was negative.
2.1.2 | Case 2
A 3 year and 8‐month‐old girl, known with Gene Xpert MTB/RIF‐
confirmed pulmonary tuberculosis (PTB), on treatment for the pre-
ceding 3 months, presented with progressive lung disease. She had
signs of large airway obstruction and increasing coughing but was
apyrexial. She had no symptoms of upper respiratory tract infection
on admission. On examination she had dullness to percussion
and decreased air entry on the right side of her chest. Her chest
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radiograph demonstrated pleural disease and mediastinal lymph
node enlargement with airway compression (Figure 1). Bronchoscopy
was performed to evaluate the severity of the airway compression
and to determine if urgent decompression of mediastinal lymph
nodes would be needed. Bronchoscopy was performed with a 4.0‐mm
videoscope passed via laryngeal mask airway (LMA). She had 50%
tracheal compression from the right; bronchus intermedius was 75%
compressed medially and laterally. The right upper lobe bronchus
was 100% occluded with a granuloma. There were also granulomas in
the right lower lobe and lingula. The procedure was completed
without complications. Specimens collected for Xpert MTB/RIF dur-
ing the procedure again confirmed the presence of drug susceptible
TB. A SARS‐COV‐2 RT‐PCR test, taken on hospital admission, was
confirmed as positive 1 day after the procedure. The child had no
known COVID‐19 contacts.
2.1.3 | Case 3
Case 3: A 17‐month‐old boy presented with severe stridor. The
medical history was not suggestive of croup and he had had no
previous episodes of croup. In the emergency ward, the child
coughed out a large object which resembled a plastic cap from a milk
bottle. Bronchoscopy was performed with a 3.0‐mm videoscope via
the nasal route, as the bottle cap appeared incomplete. Broncho-
scopy confirmed that the object was lodged between the true vocal
cords, with significant swelling and granulation tissue on both cords.
The rest of the airway was clear. The following day, the child de-
veloped symptoms suggestive of COVID‐19 infection (fever and
coughing) and COVID‐19 was confirmed on RT‐PCR. His chest
radiograph showed left lower lobe air‐space disease (Figure 1).
No household contacts were identified. He was discharged 2 days
later and made a complete recovery.
2.1.4 | Case 4
A 16‐day‐old male baby presented with severe progressive life
threating inspiratory and expiratory stridor since birth. The baby was
HIV‐exposed, but uninfected. He had no fever or other respiratory
symptoms. Bronchoscopy was performed under anesthesia with
2.8mm videoscope via the nasal approach in a spontaneously
breathing baby. We found bilateral vocal cord palsy and a pulsatile
(possibly vascular) compression anterior in the middle third of the
trachea. The procedure was completed without complications. A
screening COVID‐19 RT‐PCR test, taken on hospital admission be-
came available the day after the bronchoscopy and was confirmed as
positive. No one in the new‐born's household contacts had symptoms
of COVID ‐19 infection.
The same group of staff members were involved in all four
bronchoscopy procedures including the bronchoscopist, anesthetist,
assistant anesthetist, and nursing personnel.
2.2 | PPE during bronchoscopy
Modified full‐face snorkel masks (SEAC Libera, SEAC, Italy) were
worn by the bronchoscopy team from the start of the COVID‐19
pandemic in South Africa as PAPR respirators were unavailable at
Tygerberg Hospital. Initially N95 respirators and visors were
worn but this distorted bronchoscopy views, especially during in-
terventional procedures. The SEAC full‐face snorkel mask has
F IGURE 1 Patient 1: Frontal chest radiograph in a high care setting with a well‐placed endotracheal tube tip and nasogastric tube tip. Lung
volumes are on the large side but this is in the context of positive pressure ventilation which accounts for this. There is no confluent
parenchymal air‐space disease or any suggestion of an interstitial process. Patient 2: Frontal chest radiograph demonstrating confluent density
behind the heart on the left in keeping with left lower lobe air‐space disease. Patient 3: Frontal chest radiograph demonstrating extensive
confluent air‐space disease with some volume loss involving the right upper lobe and right lower lobe. There are features of a right pleural
effusion. The bronchus intermedius and possibly right upper lobe bronchus are narrowed suggesting compression by right hilar and subcarinal
lymphadenopathy. The trachea is also bowed and displaced to the left in keeping with right paratracheal lymphadenopathy. Features are of
airway compression suggest pulmonary TB with associated complications of parenchymal collapse/consolidation and pleural effusion.
TB, tuberculosis
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separate inhalation and exhalation circuits, with one‐way exhala-
tion valves, ensuring CO2 clearance. The snorkel was removed and
replaced with a three‐dimensional (3D) printed adapter (provided
with the mask from the supplier), with an O‐ring inserted in a
groove at the base of the adapter. A heat and moisture exchanger
(HME) filter (Clear Guard, Intersurgical, South Africa) was at-
tached to the adapter (Figures 2, 3, and 4). Face fit testing, as per
the manufacturer's specifications, was performed for each HCW to
determine the size of mask and optimal strap position. The rapid
suction test (quantitative negative pressure test) was performed
to confirm seal at each donning episode. This test was performed
by placing a hand over the filter and inhaling deeply. If the mask
sealed adequately, a vacuum would be created inside the mask
(due to the mask's low internal volume) and a sensation of stifling
would be experienced. The mask was cleaned with quaternary
ammonium wipes or a 0.1% hypochlorite solution. Standardized
donning, doffing, and mask decontamination procedures were
developed and implemented. The HME filters were exchanged
every 7 days unless damaged or clearly wet. To date, there have
been no COVID‐19 infections among the bronchoscopy team staff,
whereas the overall Tygerberg Hospital staff COVID‐19 pre-
valence rate has exceeded 13.5% (667/4949) (personal commu-
nication Dr Jack Meintjes).
2.3 | Bronchoscopy anesthetic technique
Four children were anesthetised for flexible bronchoscopy (FB) with
SARS‐CoV‐2 results that turned out to be positive after the proce-
dures were performed. Preoperatively the children were screened
for COVID‐19 and all were asymptomatic. In our institution an-
esthesia for airway procedures, which include bronchoscopy, man-
date the wearing of PPE, which usually (pre‐COVID‐19) consisted of
an N95 respirator, face shield/visor, or eye protective goggles and an
unsterile waterproof gown.
Additional infection prevention measures implemented during
the COVID‐19 pandemic included the wearing of surgical face masks
by patients and caregivers (source control), and only allowing the
patient and caregiver to enter the bronchoscopy theater once all
preparations are complete, thereby, reducing the exposure time for
staff. Induction of anesthesia, on the lap of a parent, is completed
with sevoflurane gas induction, fraction of inspired oxygen (FiO2) of
0.5 in air. Standard American Society of Anesthesiologists monitoring
was applied, including capnography. Intravenous access was estab-
lished and alfentanil 10 μg/kg administered to obtund the airway
reflexes and the response to placement of a LMA. The LMA was held
in position by the anesthetist ensuring a tight seal. Spontaneous
breathing was maintained with positive pressure ventilation by hand,
only when necessary, to prevent the potential of aerosol generation.
Placement of a Rusch Mainz Universal Adapter between the anes-
thetic breathing circuit and the LMA ensured a sealed channel for
both bronchoscopy and ventilation while minimizing the risk for
aerosolization.
Lignocaine 1% was injected onto the vocal cords via FB working
channel, to a maximum dose of 9 mg/kg. Baseline oxygen saturations
were above 96% for all the children, and no desaturation episodes
F IGURE 2 A, SEAC Libera PPE mask (silicone straps) and (B) SEAC Magica (material straps) PPE mask. PPE, personal protective equipment
[Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 3 A, Standard N95 mask and visor and (B) SEAC Liber
during bronchoscopy at Tygerberg Hospital [Color figure can be
viewed at wileyonlinelibrary.com]
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were recorded during the course of the anesthesia with the max-
imum FiO2 of 0.5. The procedures were uneventful lasting between
5 and 10minute and the LMAs were removed under deep sevo-
flurane anesthesia. Once stable the patients were transported to the
recovery room in the left lateral head down recovery position
breathing spontaneously. An oxygen face mask with an FiO2 of 0.4
was applied if pulse oximetry readings were less than 94%. Patients
returned safely to the ward with no complications. All bronchoscopy
and patient monitoring equipment and the bronchoscopy theater
surfaces were cleaned as per hospital COVID‐19 cleaning protocols.
3 | DISCUSSION
We have described four cases of pediatric COVID‐19, where COVID‐19
was not clinically suspected, but urgent bronchoscopy was required,
requiring adaptation of bronchoscopy and anesthetic technique as well
as type of PPE used.
None of these cases were suggestive of COVID‐19 infection
upon presentation to hospital. Two of the cases presented with a
history of possible foreign body aspiration, one with congenital stri-
dor and one with complicated PTB and progressive airway obstruc-
tion. Owing to the severity of the clinical presentation, it was not
possible to wait for the COVID‐19 result before these procedures.
This highlights the difficulty of doing bronchoscopy in the COVID‐19
era, as it is often clinically necessary and urgently indicated.
The fast transmission rate of SARS‐CoV‐2 virus, long incubation
period and asymptomatic spread have led to a large number of
deaths. Especially in the older population with underlying
comorbidities.16 What is of particular concern is the spread of
SARS‐COV‐2 to HCW who are thought to have an increased risk to
acquire infection.
The first transmission to HCW was described in January 2020
and the first reported fatality related to COVID‐19 was an otolar-
yngologist from Wuhan, China.17 The airways of infected patients
with COVID‐19 have been shown to have a very high viral load.18
Airway procedures result in the aerosolization of the virus, thus
placing HCWs at high‐risk of infection.13,14,19 It has been re-
commended that only essential procedures be performed during the
COVID‐19 pandemic and that the appropriate PPE be used and
personnel should be limited to only essential staff.20
The SEAC Libera (SEACSUB, Italy) full‐face snorkel mask (with
adapter) was fitted with an Intersurgical Clear‐Guard filter (Inter-
surgical, South Africa) and have been adapted by replacing the
snorkel with a 3D printed adapter and the addition of a bacterial/
viral filter (Figure 2). The SEAC PPE mask conforms to the provisions
of the EU regulation 425/2016 regarding PPE. These masks are ideal
for PPE due to their ability to withstand the intrusion of water. The
silicone face skirt is hypoallergenic and the mask has a low internal
volume. The safety of the SEAC mask is ensured by separate air inlet
and outlet channels, thereby, decreasing breathing effort, simulating
natural breathing, and preventing CO2 retention. End‐tidal CO2
(ETCO2) and ETO2 have shown to be stable in two case studies with
only single participants21,22 as well as in similar masks that have been
used in endoscopic procedures.23,24
Bronchoscopy has a very limited role in the management of
COVID‐19 positive children because most have mild disease and do
not require bronchoscopy. Xia et al25 reported that COVID‐19 dis-
ease in children is characterized by mild pneumonia, with only 10% of
patients developing tachypnea. Pneumonic changes were confirmed
by chest CT‐scan as in most children the chest x‐ray appearance was
normal.
Noninvasive testing can confirm the diagnosis of COVID‐19 and
bronchoscopy is, therefore, seldom required. Rigid bronchoscopy
should be avoided, due to the increased risk of droplet spread during
the COVID‐19 pandemic.26 Rather, flexible bronchoscopy should be
performed first in COVID‐19 positive individuals or in unknown
cases, to determine if rigid bronchoscopy is indicated. Foreign bodies
can also be removed with flexible bronchoscopy, if required. Aero-
solization during bronchoscopy via LMA can be reduced by covering
the swivel connection with plastic tape or Tegaderm. Collecting
bronchoalveolar lavages may increase the risk of droplet spread for
HCWs involved. This should be done with care and only if it will
benefit the patients.
At the peak of the epidemic in South Africa the demand for
testing was extremely high, significantly delaying test results. It be-
came impractical to wait for these results before bronchoscopy,
especially seeing that the bronchoscopy procedures mentioned were
urgently indicated. These bronchoscopies were performed under
strict precautions, as with any patient who is a person under in-
vestigation. All bronchoscopy patients with an unknown COVID‐19
status should be regarded as potentially COVID‐19 infected and
F IGURE 4 Modifications to face mask: detach snorkel, attach adapter with O‐ring in groove and place HME filter on top of adapter.
HME, heat and moisture exchanger [Color figure can be viewed at wileyonlinelibrary.com]
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managed as per the policies for COVID‐19‐positive cases. We ad-
vocate that full PPE (as described above) should be worn by all staff
involved in pediatric bronchoscopy during the COVID‐19 pandemic.
Currently, there are no specific pediatric COVID‐19‐related guide-
lines published for bronchoscopy.26,27
4 | CONCLUSION
Bronchoscopy is a high‐risk procedure, with great potential for
hospital‐acquired COVID‐19 exposure and infection among HCWs
during the COVID‐ 19 pandemic. Bronchoscopy can be done per-
formed in children with COVID‐19 if infection prevention protocols
are strictly adhered to and HCWs wear appropriate PPE at all times.
Modified full‐face masks are a practical and safe alternative to fil-
tering facepieces for use in bronchoscopy (Table 1).
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